Last $74.62 USD
Change Today -0.01 / -0.01%
Volume 10.5M
MDT On Other Exchanges
New York
As of 8:04 PM 12/19/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Michael J. Coyle

Executive Vice President and Group President of Cardiac & Vascular Group, Medtronic, Inc.
AgeTotal Calculated CompensationThis person is connected to 0 board members in 0 different organizations across 5 different industries.

As of Fiscal Year 2014


Mr. Michael J. Coyle has been an Executive Vice President and Group President of Cardiac & Vascular Group at Medtronic, Inc., since December 2009 and served as its Group President of Cardiac Rhythm Disease Management (CRDM) CardioVascular and Physio-Control Business Units since December 2009. Mr. Coyle serves as a Limited Partner of Lakeshore Capital Partners, LLC. Mr. Coyle serves as a Consultant on device related issues to various clients in the Medical Device, Venture ...

Read Full Background

Corporate Headquarters*

710 Medtronic Parkway
Minneapolis, Minnesota 55432

United States

Phone: 763-514-4000
Fax: --

Board Members Memberships*

Former Director, Chairman of Governance & Nominating Committee and Member of Compensation Committee
Former Director, Member of Audit Committee and Member of 162(m) Committee


Case Western Reserve University
University of Pennsylvania - The Wharton School

Other Affiliations*

Annual Compensation*

Total Annual Compensation$724,942

Stock Options*

Restricted Stock Awards$767,012
All Other Compensation$106,257
Exercisable Options137,931
Exercisable Options Value$2,806,928
Unexercisable Options175,489
Unexercisable Options Value$2,642,168
Total Value of Options$5,449,095
Total Number of Options313,420

Total Compensation*

Total Annual Cash Compensation$2,137,992
Total Short Term Compensation$724,942
Other Long Term Compensation$873,269
Total Calculated Compensation$3,591,420
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
MDT:US $74.62 USD -0.01


Vincent A. Forlenza BDChairman, Chief Executive Officer and President
Becton, Dickinson and Company
David E. I. Pyott Chairman and Chief Executive Officer
Allergan Inc.
Yoshihiko Hatanaka Chief Executive Officer, President and Representative Director
Astellas Pharma, Inc.
Ulf Mark Schneider Chairman of the Management Board - Fresenius Management Se, Chief Executive Officer of Fresenius Management Se and President of Fresenius Management Se
Fresenius SE & Co KGaA
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact MEDTRONIC INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at